-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, R+/gH4VB2wvVeH9BzVBZ7FRBkU8scjTPES9qRDVxEhny0BMMEKPEzrfBPrAIGbJ5 52pkzztycly1zmLfbullKg== 0000898432-07-000463.txt : 20070607 0000898432-07-000463.hdr.sgml : 20070607 20070607122258 ACCESSION NUMBER: 0000898432-07-000463 CONFORMED SUBMISSION TYPE: 5 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20061231 FILED AS OF DATE: 20070607 DATE AS OF CHANGE: 20070607 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Ardea Biosciences, Inc./DE CENTRAL INDEX KEY: 0001103390 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 943200380 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 2131 PALOMAR ROAD STREET 2: SUITE 300 CITY: CARLSBAD STATE: CA ZIP: 92011 BUSINESS PHONE: 760-602-8422 MAIL ADDRESS: STREET 1: 2131 PALOMAR ROAD STREET 2: SUITE 300 CITY: CARLSBAD STATE: CA ZIP: 92011 FORMER COMPANY: FORMER CONFORMED NAME: INTRABIOTICS PHARMACEUTICALS INC /DE DATE OF NAME CHANGE: 20000127 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: ANDREEFF DANE CENTRAL INDEX KEY: 0001201810 FILING VALUES: FORM TYPE: 5 SEC ACT: 1934 Act SEC FILE NUMBER: 000-29993 FILM NUMBER: 07906068 BUSINESS ADDRESS: STREET 1: C/O ANDREEFF EQUITY ADVISORS LLC STREET 2: 450 LAUREL STREET STE 2105 CITY: BATON ROUGE STATE: LA ZIP: 70801 BUSINESS PHONE: 2253447780 MAIL ADDRESS: STREET 1: C/O ANDREEFF EQUITY ADVISORS LLC STREET 2: 450 LAUREL ST STE 2105 CITY: BATON ROUGE STATE: LA ZIP: 70801 5 1 andreeff2_form5ex.xml X0202 5 2006-12-31 0 0 1 0001103390 Ardea Biosciences, Inc./DE ARDC 0001201810 ANDREEFF DANE C/O ANDREEFF EQUITY ADVISORS LLC 450 LAUREL ST STE 2105 BATON ROUGE LA 70801 0 0 1 0 Common Stock 2007-04-02 4 S 0 16350 4.7580 D 1203848 I See footnote Common Stock 2006-02-13 4 P 0 71932 3.5000 A 1203848 I See footnote Common Stock 2006-04-03 4 P 0 2795 3.5400 A 1203848 I See footnote Common Stock 2006-04-04 4 P 0 1993 3.5500 A 1203848 I See footnote Common Stock 2006-04-05 4 P 0 10164 3.5500 A 1203848 I See footnote Common Stock 2006-04-10 4 P 0 8244 3.6100 A 1203848 I See footnote Common Stock 2006-04-11 4 P 0 2886 3.6200 A 1203848 I See footnote Common Stock 2006-04-17 4 P 0 8733 3.6500 A 1203848 I See footnote Common Stock 2006-04-18 4 P 0 1561 3.6500 A 1203848 I See footnote Common Stock 2006-04-19 4 P 0 4698 3.6500 A 1203848 I See footnote Common Stock 2006-04-20 4 P 0 299 3.6500 A 1203848 I See footnote Common Stock 2006-04-21 4 P 0 1292 3.6500 A 1203848 I See footnote Common Stock 2006-11-01 4 P 0 17526 3.9899 A 1203848 I See footnote Common Stock 2007-01-03 4 P 0 20165 4.3600 A 1203848 I See footnote Common Stock 2007-01-08 4 P 0 2400 4.7000 A 1203848 I See footnote Common Stock 2007-04-30 4 P 0 8333 5.4766 A 1203848 I See footnote Common Stock 2007-05-02 4 P 0 163 5.5100 A 1203848 I See footnote Common Stock 2007-05-02 4 P 0 2991 5.5000 A 1203848 I See footnote Common Stock 2006-05-01 4 S 0 9750 3.5500 D 1203848 I See footnote This transaction was made by a fund that is not, itself, a 10% owner of the issuer's securities. The reporting person is reporting this transaction because he is the managing member of the fund's general partner and thus may be deemed an indirect beneficial owner of the fund's holdings. When these holdings are aggregated with the reporting person's other indirect holdings of this issuer's securities, he may be deemed an indirect beneficial owner of 10% or more of the issuer's securities. This transaction was made by a fund that is not, itself, a 10% owner of the issuer's securities. The reporting person is reporting this transaction because he is a Director of the fund and thus may be deemed an indirect beneficial owner of the fund's holdings. When these holdings are aggregated with the reporting person's other indirect holdings of this issuer's securities, he may be deemed an indirect beneficial owner of 10% or more of the issuer's securities. The reporting person may be deemed to have become a 10% owner of the issuer's securities on this date. These holdings were reportable on a Form 3. The SEC's reporting system would not accept that form type to be listed in Table 1 of this Form 5 filing. /s/ Dane Andreeff 2007-06-07 -----END PRIVACY-ENHANCED MESSAGE-----